Atlas Trials

Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer

Clinical trial NCT04163237 · UNKNOWN

Trial details

NCT number
NCT04163237
Sponsor
Guangxi Medical University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced Liver Cancer
Start date
2019-12-01
Primary completion
2020-10-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.